This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A 2.5-Year Follow-up Study

Bruce J. Rounsaville, MD; Thomas R. Kosten, MD; Myrna M. Weissman, PhD; Herbert D. Kleber, MD

Arch Gen Psychiatry. 1986;43(8):739-745.

Abstract
• Two different methods for assessing psychopathology in opiate addicts were compared as predictors of long-term treatment outcome: (1) categorical psychiatric diagnosis using the Schedule for Affective Disorders and Schizophrenia— Lifetime Version and the Research Diagnostic Criteria and (2) global rating of psychiatric impairment using the Psychiatric Severity scale of the Addiction Severity Index (ASI). Follow-up interviews were completed 2.5 years after treatment seeking in 76% of a sample of 361 opiate addicts. Five dimensions of treatment outcome were assessed, including current functioning, psychosocial adjustment, substance use impairment, legal problems, and medical disability. Most lifetime psychiatric disorders with a prevalence of greater than 10% were significantly related to the outcome dimensions of current functioning and/or psychosocial adjustment and were unrelated to substance use impairment, legal problems, and medical disability. The ASI Psychiatric Severity rating more robustly predicted poorer functioning in the same two areas and less severe legal problems. While controlling for ASI Psychiatric Severity, the only Research Diagnostic Criteria diagnosis that remained significantly related to treatment outcome was major depression, suggesting that, as regards their prognostic characteristics, the other diagnoses are accounted for by a global underlying severity dimension.

Author Affiliations
From the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.

Footnotes
Accepted for publication Nov 22, 1985.

Reprint requests to Substance Abuse Treatment Unit, Yale School of Medicine, 904 Howard Ave, Suite 2E, New Haven, CT 06519 (Dr Rounsaville).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

New Medication Strategies for Comorbid Substance Use and Bipolar Affective Disorders
Kosten and Kosten
Focus 2007;5:262-269.
ABSTRACT | FULL TEXT  

Impact of Program Services on Treatment Outcomes of Patients With Comorbid Mental and Substance Use Disorders
Grella and Stein
Psychiatr. Serv. 2006;57:1007-1015.
ABSTRACT | FULL TEXT  

Association Between Concurrent Depression and Anxiety and Six-Month Outcome of Addiction Treatment
Charney et al.
Psychiatr. Serv. 2005;56:927-933.
ABSTRACT | FULL TEXT  

Dual diagnosis: management within a psychosocial context
Abou-Saleh
Adv. Psychiatr. Treat. 2004;10:352-360.
ABSTRACT | FULL TEXT  

Pharmacotherapy Plus Psychotherapy for Treatment of Depression in Active Injection Drug Users
Stein et al.
Arch Gen Psychiatry 2004;61:152-159.
ABSTRACT | FULL TEXT  

Effects of Major Depression on Remission and Relapse of Substance Dependence
Hasin et al.
Arch Gen Psychiatry 2002;59:375-380.
ABSTRACT | FULL TEXT  

A National Survey of Care for Persons With Co-occurring Mental and Substance Use Disorders
Watkins et al.
Psychiatr. Serv. 2001;52:1062-1068.
ABSTRACT | FULL TEXT  

A Review of Temporal Effects and Outcome Predictors in Substance Abuse Treatment Studies With Long-Term Follow-Ups: Preliminary Results and Methodological Issues
McKay and Weiss
Eval Rev 2001;25:113-161.
ABSTRACT  

Adverse Effect of Child Abuse Victimization Among Substance-Using Women in Treatment
KANG et al.
J Interpers Violence 1999;14:657-670.
ABSTRACT  

Overcoming Service Barriers for Homeless Persons With Serious Psychiatric Disorders
Calloway and Morrissey
Psychiatr. Serv. 1998;49:1568-1572.
ABSTRACT | FULL TEXT  

Imipramine Treatment of Opiate-Dependent Patients With Depressive Disorders: A Placebo-Controlled Trial
Nunes et al.
Arch Gen Psychiatry 1998;55:153-160.
ABSTRACT | FULL TEXT  

The National Institute on Drug Abuse Collaborative Cocaine Treatment Study: Rationale and Methods
Crits-Christoph et al.
Arch Gen Psychiatry 1997;54:721-726.
ABSTRACT  

Psychiatric and Substance Use Comorbidity Among Treatment-Seeking Opioid Abusers
Brooner et al.
Arch Gen Psychiatry 1997;54:71-80.
ABSTRACT  

Ineffective Use of Psychoactive Drugs Methadone Treatment Is No Exception
Cooper
JAMA 1992;267:281-282.
ABSTRACT  

Psychiatric Disorders in Relatives of Probands With Opiate Addiction
Rounsaville et al.
Arch Gen Psychiatry 1991;48:33-42.
ABSTRACT  

Psychiatric Diagnoses of Treatment-Seeking Cocaine Abusers
Rounsaville et al.
Arch Gen Psychiatry 1991;48:43-51.
ABSTRACT  

Long-term Therapeutic Use of Benzodiazepines: I. Effects of Abrupt Discontinuation
Rickels et al.
Arch Gen Psychiatry 1990;47:899-907.
ABSTRACT  

Psychopathology as a Predictor of Treatment Outcome in Alcoholics
Rounsaville et al.
Arch Gen Psychiatry 1987;44:505-513.
ABSTRACT  

A 2.5-Year Follow-up of Depression, Life Crises, and Treatment Effects on Abstinence Among Opioid Addicts
Kosten et al.
Arch Gen Psychiatry 1986;43:733-738.
ABSTRACT